ICPOEP2016
3rd International Conference on Phase 1 and Early Phase Clinical Trials
Innovative Drug Development for the Future

MAIN CONFERENCE
3 - 4 November 2016
Hyatt Regency Hong Kong, Tsim Sha Tsui,
18 Hanoi Road, Tsim Sha Tsui, Kowloon, Hong Kong

PRE-CONFERENCE WORKSHOP AND OPEN DAY
2 November 2016
HKU Phase 1 Clinical Trials Centre,
2/F, Block K, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong

Overview

Following the success of ICPOEP2015, we are delighted to announce

ICPOEP2016 to be held during 3-4 November 2016 in Hong Kong. This year,

we will also have a pre-conference workshop and an open day of the

HKU Phase 1 Clinical Trials Centre on 2 November 2016.

Following the success of ICPOEP2015, we are delighted to announce ICPOEP2016 to be held during 3-4 November 2016 in Hong Kong. This year, we will also have a pre-conference workshop and an open day of the HKU Phase 1 Clinical Trials Centre on 2 November 2016.

Phase 1 and early phase clinical trial activities are blooming in Asia. With renowned clinical trial experts and increasing number of professional clinical trial facilities, Asian clinical trial institutions are playing more and more important roles in phase 1 and early phase new drug development.

In this event, experts from North America, Europe and Asia will share their insight and wisdom on the latest trends on new drug development in various disease areas, in Asia and worldwide.

Please join and take this precious opportunity to meet and exchange ideas with the international speakers and participants.


Support from New β Innovation for the organization of this conference is gratefully acknowledged.

Organizer

The University of Hong Kong Clinical Trials Centre (HKU-CTC) is an academic clinical research organization established under The University of Hong Kong (HKU) in 1998. It has been authorized as the central platform for management and coordination of clinical studies under HKU and its affiliated teaching hospital – Queen Mary Hospital (QMH).

 
LKS Faculty of Medicine
Clinical Trials Centre

HKU-CTC is devoted to partnering with clinical investigators, research organizations and the healthcare industry in advancing human healthcare by promoting, attracting and facilitating clinical studies of various natures, such as investigator-initiated and industry-sponsored clinical studies; interventional and non-interventional clinical studies; clinical studies on various medicinal products including small-molecule chemical drugs, biopharmaceuticals, medical devices, diagnostics, traditional/proprietary Chinese medicines, herbal medicines and health supplements; phase 1 to 4 clinical trials; and clinical studies on clinical procedures and methods.

Over the years, HKU-CTC has developed into a leading, full-service professional organization offering one-stop clinical research solutions. Since its establishment, HKU-CTC has already facilitated close to 1,000 sponsored clinical studies and over 150 investigator-initiated clinical studies in collaboration with more than 200 sponsors around the world and some 100 clinical investigators of HKU, QMH and other hospitals and clinics in Hong Kong.

For more information about HKU-CTC, please visit HKU-CTC's website at www.hkuctc.com.


Committees

Organizing Committee
CHAIR: Professor Karen Lam, Chairman, Clinical Trials Centre, The University of Hong Kong
MEMBERS:     Professor Yu-lung Lau, Chief Director, Clinical Trials Centre, The University of Hong Kong
Professor Bernard Cheung, Medical Director, Phase 1 Clinical Trials Centre, The University of Hong Kong
Dr. Tommy Cheung, Deputy Medical Director (Clinical Pharmacology), Phase 1 Clinical Trials Centre, The University of Hong Kong
Dr. Joanne Chiu, Deputy Medical Director (Oncology), Phase 1 Clinical Trials Centre, The University of Hong Kong
Dr. Koon-Ho Chan, Clinical Associate Professor, Department of Medicine, The University of Hong Kong
Dr. Thomas Yau, Clinical Associate Professor, Department of Medicine, The University of Hong Kong
Henry Yau, Managing Director, Honorary Assistant Professor, Clinical Trials Centre, The University of Hong Kong


Scientific Committee
CO-CHAIRS:Professor Bernard Cheung, Medical Director, Phase 1 Clinical Trials Centre, The University of Hong Kong
Dr. Thomas Yau, Clinical Associate Professor, Department of Medicine, The University of Hong Kong
MEMBERS:    Dr. Joanne Chiu, Deputy Medical Director (Oncology), Phase 1 Clinical Trials Centre, The University of Hong Kong
Dr. Koon-Ho Chan, Clinical Associate Professor, Department of Medicine, The University of Hong Kong
Dr. Roland Leung, Associate Consultant, Department of Medicine, Queen Mary Hospital
Prof. Karen Lam
Prof. Yu-lung Lau
Prof. Bernard Cheung
Dr. Tommy Cheung
Dr. Joanne Chiu
imaDr. Koon-ho Chan
Dr. Roland Leung
Dr. Thomas Yau
Dr. Henry Yau

Main Conference


Hyatt Regency Hong Kong,
Tsim Sha Tsui

18 Hanoi Road, Tsim Sha Tsui, Kowloon, Hong Kong, China

Participants could enjoy a special rate at conference hotel by making a reservation via the following link:
KING / TWIN Room






Pre-Conference Workshop and Open Day


HKU Phase 1 Clinical Trials Centre
2/F, Block K, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China